Perlmutter Cancer Center at NYU Langone Health — New York, New York

Perlmutter Cancer Center at NYU Langone Health is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Perlmutter Cancer Center at NYU Langone Health has participated in 6 clinical trials with 4 currently active.

Therapeutic areas: Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC).

Sponsors: Revolution Medicines, Inc., University of Arkansas, Celldex Therapeutics.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Perlmutter Cancer Center at NYU Langone Health?

Perlmutter Cancer Center at NYU Langone Health has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Perlmutter Cancer Center at NYU Langone Health conducted?

Perlmutter Cancer Center at NYU Langone Health has 6 clinical trials on record, with 4 currently active. Their work covers Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC).

Is Perlmutter Cancer Center at NYU Langone Health accredited by Crixeo Health?

Yes — Perlmutter Cancer Center at NYU Langone Health holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Perlmutter Cancer Center at NYU Langone Health?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.